Doctors Note Logo

Published on: 9/14/2026

Can metoprolol slow my heart rate enough to be dangerous?

Yes, metoprolol can slow the heart rate too much, a condition called bradycardia, and in some cases that slowdown becomes dangerous. Concerning signs include a resting pulse under 60 paired with dizziness, fainting or near fainting, unusual fatigue, shortness of breath, chest pain or confusion, while risk climbs with higher doses, older age, kidney or liver problems, existing conduction disease, and use alongside other rate lowering drugs such as diltiazem, verapamil, digoxin or amiodarone. Never stop metoprolol suddenly, since rebound rapid heart rate, spiking blood pressure and heart attack risk can follow, so dose changes belong with your prescriber; there are several factors to consider, and the important details are explained below.

Because a slow pulse can be harmless in one person and an emergency in another, the fastest way to sort out where you fall is to review your exact symptoms, medications and vital signs together rather than in isolation. Take a free, instant, online symptom check to better understand what may be driving your symptoms and what step to take next, whether that is monitoring at home, calling your prescriber, or seeking urgent care.

Last reviewed for medical accuracy: 09/13/2026

answer background

Explanation

Can Metoprolol Slow My Heart Rate Enough to Be Dangerous?

Metoprolol is a commonly prescribed beta-blocker used to treat high blood pressure, angina (chest pain), and certain types of heart rhythm disorders. By blocking beta-1 receptors in the heart, metoprolol reduces the force of contraction and slows the heart rate. For most people, this effect helps the heart work more efficiently and lowers the risk of complications over time. However, if the heart rate drops too low—a condition called bradycardia—symptoms can arise that may require prompt attention.

How Metoprolol Works on Heart Rate
• Metoprolol selectively blocks beta-1 receptors, which mediate the heart’s response to adrenaline.
• This blockade reduces the speed at which electrical impulses travel through the heart, lowering heart rate by an average of 5–15 beats per minute.
• In people with fast or irregular heart rhythms, this slowing can restore a more normal pattern.
• In healthy hearts, the reduction is usually mild and well tolerated.

What Is Bradycardia, and When Is It Dangerous?
Bradycardia refers to a resting heart rate below 60 beats per minute (bpm). For many adults—especially athletes or those in good cardiovascular shape—a resting rate of 50–59 bpm may be normal and symptom-free. Metoprolol can push some people’s rate below this range. Bradycardia becomes a concern when it leads to:

  • Symptoms such as lightheadedness, extreme fatigue or shortness of breath.
  • Inadequate blood flow to organs, causing confusion or chest discomfort.
  • Heart block (impaired electrical conduction), leading to pauses in the heartbeat.
  • Blood pressure that falls too low, risking dizziness or fainting.

Dangerous thresholds vary by individual, but generally:

  • Resting rate <50 bpm with symptoms warrants evaluation.
  • Persistent rate <40 bpm is a red flag, even without obvious symptoms.

Who’s at Higher Risk of Excessive Slowing?
Certain factors can make bradycardia more likely when taking metoprolol:

  • High starting doses or rapid dose escalations.
  • Concomitant use of other heart-rate-lowering drugs (e.g., diltiazem, verapamil, digoxin).
  • Older age and pre-existing conduction system disease (e.g., sinus node dysfunction, AV block).
  • Electrolyte imbalances (particularly high potassium).
  • Poor kidney function, which can cause drug accumulation.
  • Use of other medications that increase metoprolol levels (e.g., certain antidepressants, antifungals).

If you have any of these risk factors, your doctor may start at a lower metoprolol dose (for example, 25 mg once daily) and titrate up slowly, with regular monitoring of heart rate and blood pressure.

Signs and Symptoms to Watch For
While mild slowing often causes no trouble, watch for:

  • Dizziness or lightheadedness, especially when standing.
  • Unusual fatigue or weakness.
  • Fainting or near-fainting episodes.
  • Shortness of breath at rest or with minimal exertion.
  • Chest pain or tightness.
  • Confusion, difficulty concentrating, or memory lapses.

If you experience any of these, check your pulse. If it’s below 50 bpm and you feel unwell, contact your healthcare provider.

Monitoring Your Heart Rate on Metoprolol
Keeping tabs on your heart rate can help catch concerning trends early:

  • Measure your resting pulse daily, first thing in the morning, before taking metoprolol.
  • Record your heart rate and any symptoms in a log. Share this with your doctor at follow-up visits.
  • Consider a wearable heart rate monitor if recommended by your provider.
  • Have your blood pressure checked regularly—either at home or in a clinic.
  • Report any sudden drops in heart rate or blood pressure, even if you feel fine.

Adjustments and Management Strategies
If metoprolol slows your heart too much, your doctor may:

  • Lower the dose or extend the dosing interval (e.g., every other day).
  • Switch to a less selective beta-blocker or a different class of blood pressure medication.
  • Address interacting medications or correct electrolyte disturbances.
  • Recommend taking metoprolol with food to slow absorption.
  • Advise on lifestyle measures—such as staying hydrated and rising slowly from chairs or beds.

Never adjust or stop metoprolol on your own. Sudden withdrawal can cause rebound hypertension, chest pain or even life-threatening heart rhythms.

When to Seek Immediate Help
Slow heart rates can be dangerous if they lead to poor blood flow or electrical blocks. Seek urgent medical attention if you experience:

  • Syncope (fainting) or severe dizziness.
  • Chest pain or pressure.
  • Extreme shortness of breath at rest.
  • Confusion, hallucinations or marked difficulty speaking.

For milder or uncertain symptoms, you might try a free, online symptom check, using the doctor approved Ubie Symptom Checker. If it suggests a concerning issue, follow up promptly with your healthcare provider.

Key Takeaways

  • Metoprolol often slows the heart rate by 5–15 bpm; mild bradycardia is usually harmless.
  • Heart rates below 50 bpm, especially under 40 bpm, may trigger symptoms and require evaluation.
  • Risk factors include high doses, other rate-lowering drugs, conduction disorders and kidney dysfunction.
  • Monitor your resting pulse, note any symptoms, and keep a log for your doctor.
  • Never adjust your dose without medical guidance to avoid rebound effects.

If you suspect your heart rate is dropping too low—or if you have any chest pain, unexplained dizziness or fainting—speak to your doctor or seek emergency care. Always discuss any potential life-threatening or serious concerns with a qualified healthcare professional.

(References)

  • * Scheinman MM, Hess DS. New antiarrhythmic drugs. Am J Surg. 1983 Jun;145(6):724-32. doi: 10.1016/0002-9610(83)90129-0. PMID: 6407348.

  • * Joye F. [Beta-blocker intoxication]. Presse Med. 2000 May 20;29(18):1027-33. PMID: 10862260.

  • * Rolfo F, Bobbio M, Angeli F, Cavallini C. [The POISE study]. G Ital Cardiol (Rome). 2008 Dec;9(12):803-7. PMID: 19119689.

  • * Rumore MM, Lee SE, Wang S, Farmer B. Metoclopramide-induced cardiac arrest. Clin Pract. 2011 Sep 28;1(4):e83. doi: 10.4081/cp.2011.e83. Epub 2011 Nov 2. PMID: 24765383; PMCID: PMC3981421.

  • * Metoprolol. 2006. PMID: 30000215.

  • * Morris J, Awosika AO, Dunham A. Metoprolol. 2026 Jan. PMID: 30422518.

  • * Beta Adrenergic Blocking Agents. 2012. PMID: 31643457.

  • * Hendriksen LC, Omes-Smit G, Koch BCP, Ikram MA, Stricker BH, Visser LE. Sex-Based Difference in the Effect of Metoprolol on Heart Rate and Bradycardia in a Population-Based Setting. J Pers Med. 2022 May 25;12(6). doi: 10.3390/jpm12060870. Epub 2022 May 25. PMID: 35743655; PMCID: PMC9224772.

  • * Collett S, Massmann A, Petry NJ, Van Heukelom J, Schultz A, Hellwig T, Baye JF. Metoprolol and CYP2D6: A Retrospective Cohort Study Evaluating Genotype-Based Outcomes. J Pers Med. 2023 Feb 26;13(3). doi: 10.3390/jpm13030416. Epub 2023 Feb 26. PMID: 36983598; PMCID: PMC10058912.

  • * Yndigegn T, Lindahl B, Mars K, Alfredsson J, Benatar J, Brandin L, Erlinge D, Hallen O, Held C, Hjalmarsson P, Johansson P, Karlström P, Kellerth T, Marandi T, Ravn-Fischer A, Sundström J, Östlund O, Hofmann R, Jernberg T, REDUCE-AMI Investigators. Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction. N Engl J Med. 2024 Apr 18;390(15):1372-1381. doi: 10.1056/NEJMoa2401479. Epub 2024 Apr 7. PMID: 38587241.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.